Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data

Cardiovascular Risk and Diseases

Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study

Diabetes Obes Metab

Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J

doi: 10.1111/dom.70214

Cardiovascular Risk and Diseases

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies

Ann Intern Med

Saeed A, Mulukutla SR, Thoma F, Lemon L, Koczo A, Reis S, Marroquin O, Kip K

doi: 10.7326/ANNALS-24-00775

Cardiovascular Risk and Diseases

Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study

Front Endocrinol (Lausanne)

Zhao X, He K, Li J, Zhou L, Liu L, Lu X, Jiang Y

doi: 10.3389/fendo.2025.1635444

COMMENTED

Cardiovascular Risk and Diseases

Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet Diabetes Endocrinol

Hauge JW, Borgeraas H, Birkeland KI, Johnson LK, Hertel JK, Hagen M, Gulseth HL, Lindberg M, Lorentzen J, Seip B, Kolotkin RL, Svanevik M, Valderhaug TG, Sandbu R, Hjelmesæth J, Hofsø D

doi: 10.1016/S2213-8587(24)00396-6

Myocardial Infarction

Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study

Lancet Diabetes Endocrinol

Smidtslund P, Harjutsalo V, Thorn V, Jansson Sigfrids F, Groop PH, Thorn LM, FinnDiane Study Group

doi: 10.1016/S2213-8587(25)00368-7

Cardiovascular Risk and Diseases

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort

Cardiovasc Diabetol

Salle L, Julla JB, Fagherazzi G, Gourdy P, Bezerra Parente E, Hanaire H, Tatulashvili S, Disse E, Franc S, Hadjadj S, Larger E, Sanz C, Vaduva P, Valero R, Bonnefond A, Cosson E, Aguayo GA, Riveline JP, SFDT1 group

doi: 10.1186/s12933-025-02789-3

Heart Failure

Mortality risk following ischaemic and non-ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000-2021

Diabetes Obes Metab

Panchal K, Lawson CA, Shabnam S, Khunti K, Zaccardi F

doi: 10.1111/dom.16413

Myocardial Infarction

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Cardiovasc Diabetol

Tonnesen PT, Olesen KKW, Gyldenkerne C, Hansen MK, Stødkilde-Jørgensen N, Thrane PG, Andersen MH, Poulsen PL, Thomsen RW, Sattar N, Sørensen HT, Maeng M

doi: 10.1186/s12933-026-03085-4

COMMENTED

Heart, Artery and Coronary Diseases

Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

J Am Heart Assoc

Deng Y, Polley EC, Herrin J, Swarna KS, Kent DM, Ross JS, Maron BA, Mickelson MM, McCoy RG

doi: 10.1161/JAHA.124.040217

Related content

Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies

Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study

Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial

Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort

Mortality risk following ischaemic and non-ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000-2021

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk